Short answer
Quest Diagnostics (DGX) filed an 8-K current report with the SEC on July 23, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Quest Diagnostics reported results for quarter ended June 30, 2026.
Quest Diagnostics 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Quest Diagnostics reported results for quarter ended June 30, 2026
- Press release contains financial results and related disclosures in Exhibit 99.1
- Investors should review Exhibit 99.1 for revenue, earnings, guidance, and operating drivers
Item EX-99.1 · Exhibit EX-99.1
- Q2 revenue $3.04B, up 10.2%, with 10.0% organic growth and requisition volume up 13.1%
- Reported diluted EPS $2.84, up 15.0%; adjusted EPS $3.12, up 19.1%
- Full-year revenue guidance raised to $11.95B–$12.05B from $11.78B–$11.90B
- Full-year reported EPS guidance raised to $9.97–$10.17; adjusted EPS to $11.05–$11.25
- Operating margin fell to 15.1% from 15.9%, while capital expenditures rose 27.0% to $138M
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Quest Diagnostics 8-K filings
Get the next DGX 8-K as it lands
Follow DGX for push alerts, or ask the research agent what this filing means.